Pembrolizumab,atezolizumab,ipilimumab,nivolumab,avelumab,durvalumab,tremelimumab
Merck,roche,bms,pfizer,astrazeneca
['thanks']
 thanks charu!
GU oncologist, clinical trialist, Director GU Oncology @CleclinicMD Tweets my own, RT/Likes not active endorsement.